AgMerch Bifenthrin 100 EC Insecticide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agmerch bifenthrin 100 ec insecticide

agmerch pty ltd - bifenthrin; n-methyl-2-pyrrolidone; liquid hydrocarbon - emulsifiable concentrate - bifenthrin pyrethroid active 100.0 g/l; n-methyl-2-pyrrolidone solvent other 50.0 g/l; liquid hydrocarbon solvent other 605.0 g/l - insecticide

AgMerch Triasulfuron 750 WG Herbicide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agmerch triasulfuron 750 wg herbicide

agmerch pty ltd - triasulfuron - water dispersible granule - triasulfuron urea-sulfonyl active 750.0 g/kg - herbicide

AgMerch Metsulfuron 600 WG Herbicide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agmerch metsulfuron 600 wg herbicide

agmerch pty ltd - metsulfuron-methyl - water dispersible granule - metsulfuron-methyl urea-sulfonyl active 600.0 g /kg - herbicide

AgMerch Imidacloprid 200 SC Insecticide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agmerch imidacloprid 200 sc insecticide

agmerch pty ltd - imidacloprid - suspension concentrate - imidacloprid guanidine active 200.0 g/l - insecticide

AgMerch Gibberellic Acid 200 WG Growth Regulator Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agmerch gibberellic acid 200 wg growth regulator

agmerch pty ltd - gibberellic acid - water dispersible granule - gibberellic acid plant growth regulator active 200.0 g /kg - growth regulator

AgMerch Mancozeb 750 WG Fungicide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agmerch mancozeb 750 wg fungicide

agmerch pty ltd - mancozeb - water dispersible granule - mancozeb carbamate-dithiocarbamate active 750.0 g/kg - fungicide

AgMerch Fluroxypyr SSD 400 Herbicide Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agmerch fluroxypyr ssd 400 herbicide

agmerch pty ltd - fluroxypyr as the methyl heptyl ester; n-methyl-2-pyrrolidone; liquid hydrocarbon - emulsifiable concentrate - fluroxypyr as the methyl heptyl ester pyridine-pyridinoxy active 400.0 g/l; n-methyl-2-pyrrolidone solvent other 46.0 g/l; liquid hydrocarbon solvent other 314.0 g/l - herbicide

Mercilon 21 New Zealand - English - Medsafe (Medicines Safety Authority)

mercilon 21

merck sharp & dohme (new zealand) limited - desogestrel 150ug;  ; ethinylestradiol 20ug;   - tablet - active: desogestrel 150ug   ethinylestradiol 20ug   excipient: colloidal silicon dioxide dl-alpha tocopherol lactose monohydrate magnesium stearate potato starch povidone stearic acid

ZOSTAVAX- zoster vaccine live injection, powder, lyophilized, for suspension
STERILE DILUENT- sterile water injection United States - English - NLM (National Library of Medicine)

zostavax- zoster vaccine live injection, powder, lyophilized, for suspension sterile diluent- sterile water injection

merck sharp & dohme llc - varicella-zoster virus strain oka/merck live antigen (unii: gpv39zgd8c) (varicella-zoster virus strain oka/merck live antigen - unii:gpv39zgd8c) - varicella-zoster virus strain oka/merck live antigen 19400 [pfu] in 0.65 ml - zostavax® is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older. limitations of use of zostavax: - zostavax is not indicated for the treatment of zoster or postherpetic neuralgia (phn). - zostavax is not indicated for prevention of primary varicella infection (chickenpox). do not administer zostavax to individuals with a history of anaphylactic/anaphylactoid reaction to gelatin, neomycin or any other component of the vaccine. neomycin allergy manifested as contact dermatitis is not a contraindication to receiving this vaccine. {1} do not administer zostavax to individuals who are immunodeficient or immunosuppressed due to disease or therapy, as serious or fatal disseminated vaccine strain varicella-zoster virus disease may occur. causes of immunodeficiency or immunosuppression may include, but are not limited to, primary or acquired immunodeficiency states, aids or other clinical manifestations of infection with human immunodeficiency